Armata Pharmaceuticals ARMP Balance Sheet (2013-2026)

NYSE ARMP
$3.70 +0.11 (+3.06%)
As of: Sep 30, 2026 · 3:28 PM EDT
Reported Financials

Armata Pharmaceuticals Quarterly Balance Sheet

Periods 54 quarters
Latest Jun 2026

Armata Pharmaceuticals reported total assets of $89.95M and total liabilities of $321.12M for the quarter ended Jun 2026, up 11.3% year over year. This balance sheet covers 54 quarters of results from Mar 2013 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Balance Sheet Mar2013 Jun2013 Sep2013 Dec2013 Mar2014 Jun2014 Sep2014 Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Assets
Current Assets
Cash & EquivalentsCash & Equiv.
12.08M10.29M46.41M36.98M25.38M14.85M25.11M12.46M23.96M13.52M37.86M26.41M17.14M9.29M11.69M4.33M14.80M8.69M4.80M24.00M
Cash & Current Investments
12.08M10.29M46.41M36.98M25.38M14.85M25.11M12.46M23.96M13.52M37.86M26.41M17.14M9.29M11.69M4.33M14.80M8.69M4.80M24.00M
Receivables - NetNet Receivables
Receivables - OtherOther Receivables
8.53M8.63M8.50M1.50M1.71M1.24M2.22M0.70M0.20M2.50M0.50M0.10M
Receivables
Prepaid Assets
0.85M1.72M1.05M2.44M6.00M3.66M12.23M5.75M4.13M2.27M2.14M3.26M3.03M1.27M1.24M1.02M1.42M1.51M1.15M0.67M
Current Assets
14.18M14.99M48.70M41.31M33.24M27.05M38.59M26.83M36.59M19.15M41.72M30.90M22.39M11.31M13.17M7.52M16.93M10.67M5.95M27.16M
Non-Current Assets
Property, Plant & Equipment (Net)PP&E (Net)
2.11M2.22M2.25M3.26M4.34M3.62M5.44M8.81M9.25M12.56M12.70M13.47M13.62M13.24M12.88M12.66M12.56M12.19M11.78M11.23M
Goodwill
3.49M3.49M3.49M3.49M3.49M3.49M3.49M3.49M3.49M3.49M3.49M3.49M3.49M3.49M3.49M3.49M3.49M3.49M3.49M3.49M
Intangibles
10.26M10.26M10.26M10.26M10.26M10.26M10.26M10.26M10.26M10.26M10.26M10.26M10.26M10.26M10.26M10.26M10.26M10.26M10.26M10.26M
Goodwill & Intangibles
13.75M13.75M13.75M13.75M13.75M13.75M13.75M13.75M13.75M13.75M13.75M13.75M13.75M13.75M13.75M13.75M13.75M13.75M13.75M13.75M
Other Non-Current Assets
1.20M1.75M5.96M5.96M5.96M5.96M5.72M5.72M5.82M5.72M5.48M5.48M5.48M5.48M5.39M5.39M5.39M5.39M4.12M4.12M
Non-Current Assets
28.49M54.77M59.07M59.68M59.64M68.79M70.18M74.38M76.18M79.21M78.64M77.41M75.85M75.13M74.08M73.27M72.59M66.21M63.85M62.79M
Assets
42.67M69.77M107.77M100.98M92.88M95.83M108.78M101.21M112.76M98.36M120.36M108.31M98.24M86.44M87.25M80.79M89.52M76.88M69.80M89.95M
Liabilities
Current Liabilities
Accounts Payables
1.81M2.27M3.44M4.02M2.98M6.03M5.00M9.58M6.70M5.69M4.61M3.85M3.71M2.06M1.61M1.54M2.00M1.71M1.45M1.85M
Notes Payables
32.39M26.35M
Dividends payables
Payables
1.81M2.27M3.44M4.02M2.98M6.03M37.39M35.94M6.70M5.69M4.61M3.85M3.71M2.06M1.61M1.54M2.00M1.71M1.45M1.85M
Accumulated Expenses
Other Accumulated Expenses
0.52M0.32M0.12M0.51M0.53M0.34M0.14M0.50M0.49M0.37M0.20M
Short term Debt
71.66M48.26M41.36M27.69M33.45M48.09M163.90M
Current Deferred Revenue
Total Current Liabilities
5.25M4.81M6.23M7.38M7.00M24.87M51.41M51.56M21.88M16.46M110.05M123.18M118.20M48.25M110.54M120.08M139.95M8.95M9.23M250.20M
Non-Current Liabilities
Non-Current Debt
22.28M23.67M35.37M22.54M15.24M103.06M87.98M42.02M
Convertible Debt
49.75M58.63M30.00M32.90M30.00M30.00M153.86M254.92M30.00M
Pension
Preferred Stock Liabilities
Non-Current Deferred Tax LiabilityNon-Current Deferred Tax
3.08M3.08M3.08M3.08M3.08M3.08M3.08M3.08M3.08M3.08M3.08M3.08M3.08M3.08M3.08M3.08M3.08M3.08M3.08M3.08M
Operating Leases
10.59M36.48M36.92M37.23M37.22M31.80M31.84M27.43M28.16M28.58M28.38M28.16M27.93M27.69M27.42M27.13M26.84M26.53M26.18M25.82M
Other Non-Current Liabilities
Total Non-Current Liabilities
Total Liabilities
18.92M44.37M46.23M47.69M47.30M59.75M86.33M82.07M125.15M130.43M176.87M154.41M149.21M134.46M141.03M150.29M185.10M295.48M381.39M321.12M
Shareholder's Equity
Total Debt
32.39M26.35M22.28M23.67M107.03M48.26M41.36M22.54M27.69M33.45M63.33M103.06M87.98M205.93M
Common Equity
23.75M25.40M61.54M53.29M45.58M36.08M22.45M19.14M-12.39M-32.06M-56.51M-46.10M-50.97M-48.02M-53.78M-69.50M-95.59M-218.60M-311.59M-231.17M
Liabilities and Shareholders Equity
42.67M69.77M107.77M100.98M92.88M95.83M108.78M101.21M112.76M98.36M120.36M108.31M98.24M86.44M87.25M80.79M89.52M76.88M69.80M89.95M
Retained Earnings
-196.81M-202.86M-211.63M-220.85M-229.46M-239.77M-254.26M-257.81M-289.00M-308.82M-333.84M-324.90M-330.33M-327.74M-334.30M-350.60M-377.24M-501.53M-616.90M-542.74M
Preferred Shares

Armata Pharmaceuticals Balance Sheet API

Pull Armata Pharmaceuticals's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=ARMP&statement=BS&frequency=Quarter&period=all&api_key=YOUR_API_KEY